Showing results (2241-2250 of 3,418) with videos related to

Sort By:
Pageof 342
Eclinicalmedicine|December 8, 2025
Measles seropositivity in previously vaccinated individuals: a systematic review and meta-analysisMohammed Mustafa, Alex S Reznik, Juan Uribe, et al.
Eclinicalmedicine|December 16, 2025
Sertraline to reduce recidivism in impulsive violent offenders (ReINVEST): a randomised double blind clinical trialTony Butler, Emaediong I Akpanekpo, Lee Knight, et al.
Eclinicalmedicine|December 3, 2025
Recipient-focused interventions to increase vaccine uptake in high and upper-middle income countries: a systematic review and network meta-analysisSarah R Davies, Annabel L Davies, Julian P T Higgins, et al.
Eclinicalmedicine|December 1, 2025
Corrigendum to 'Artificial intelligence-augmented ultrasound diagnosis of follicular-patterned thyroid neoplasms: a multicenter retrospective study' [EClinicalMedicine Volume 86 (2025)/103351]Hui Shen, Shufang Pei, Yue Huang, et al.
Eclinicalmedicine|January 19, 2026
Operationalising social transition in trans and gender diverse youth: a scoping review of definitions and measuresWill Conabere, Francesca Lami, Hannah Andrews, et al.
Eclinicalmedicine|January 19, 2026
Double reflex testing for anti-HDV antibody following an HBsAg-positive test result and HDV RNA in those anti-HDV positive: a global systematic review and meta-analysisFeifei Li, Yusha Tao, Chengxin Fan, et al.
Eclinicalmedicine|January 19, 2026
Twelve mutations, three trials, and five different labels: PARP inhibitors regulatory inconsistencies in prostate cancersSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Hans M Westgeest, Timothée Olivier
Eclinicalmedicine|January 26, 2026
Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort studyAleksander M Bogdanski, Derk C F Klatte, Bert A Bonsing, et al.
Eclinicalmedicine|January 19, 2026
Sleep alterations in substance use disorders: a systematic review and meta-analysisHenrique Nunes Pereira Oliva, Tiago Paiva Prudente, Alisson M Paredes Naveda, et al.
Eclinicalmedicine|January 15, 2026
Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation studyWynne Wijaya, Thomas Morris, Martin D Forster, et al.
Pageof 342